Perioperative management of patients with rheumatic disorders: problems and solutions

Currently management of patients with rheumatic disorders (RD) involves not only application of all of the known spectrum of mediations in accordance with current guidelines and algorithms but also timely use of high-tech medical care, for example, endoprosthesis of the large joints, spinal surgery,...

Full description

Bibliographic Details
Main Authors: A. A. Klimenko, A. A. Kondrashov
Format: Article
Language:Russian
Published: ABV-press 2019-08-01
Series:Klinicist
Subjects:
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/382
id doaj-6faff7c929a948f98cffaf7d3e04906b
record_format Article
spelling doaj-6faff7c929a948f98cffaf7d3e04906b2021-08-02T08:49:46ZrusABV-pressKlinicist1818-83382019-08-01131-2111810.17650/1818-8338-2019-13-1-2-11-18313Perioperative management of patients with rheumatic disorders: problems and solutionsA. A. Klimenko0A. A. Kondrashov1Department of Faculty Therapy named after аcad. A.I. Nesterov, N. I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaDepartment of Faculty Therapy named after аcad. A.I. Nesterov, N. I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaCurrently management of patients with rheumatic disorders (RD) involves not only application of all of the known spectrum of mediations in accordance with current guidelines and algorithms but also timely use of high-tech medical care, for example, endoprosthesis of the large joints, spinal surgery, dental care, endovascular surgery, aimed at decreasing the level of disability and improving patients’ quality of life. The article considers modern approaches to management of patients with RD in the perioperative period, special emphasis is given to administration of background anti-inflammatory and genetically engineered biological medications, as well as prevention of thrombosis of the deep veins and thromboembolic complications. In the postoperative period, use of pharmacological control of development of “painful endoprosthesis” is vital as it is the main cause of unsatisfaction with the outcome of orthopedic aid. An effective method for controlling pain syndrome in patients with RD is use of non-steroidal anti-inflammatory drugs (NSAIDs). Selection of a specific NSAID should be based on the knowledge of gastrointestinal and cardiovascular side effects, as well as evidence of effectiveness in the perioperative period. In the group of patients with RD, namely with ankylosing spondylitis and psoriatic arthritis, prevention of heterotopic ossification after orthopedic manipulations, endoprosthesis is very important. Considering high comorbidity in RD, it is necessary to determine perioperative risk taking into account patient’s condition and operative urgency: to evaluate clinical features of the main and concomitant disorder (ischemic heart disease, cerebrovascular pathology, diabetes mellitus, chronic kidney disease), type of the surgery, results of electrocardiogram at rest, lab tests, and other noninvasive procedures. Correct planning of management of the perioperative period in patients with RD, adequate pain relief prior to surgery and after it, early activization are the main elements of rehabilitation of patients with pathologies of the locomotor apparatus.https://klinitsist.abvpress.ru/Klin/article/view/382rheumatic disordersperioperative periodendoprosthesispain reliefnon-steroidal anti-inflammatory drugsmeloxicamcomorbidityperioperative risk“painful endoprosthesis”heterotopic ossificationbackground therapy
collection DOAJ
language Russian
format Article
sources DOAJ
author A. A. Klimenko
A. A. Kondrashov
spellingShingle A. A. Klimenko
A. A. Kondrashov
Perioperative management of patients with rheumatic disorders: problems and solutions
Klinicist
rheumatic disorders
perioperative period
endoprosthesis
pain relief
non-steroidal anti-inflammatory drugs
meloxicam
comorbidity
perioperative risk
“painful endoprosthesis”
heterotopic ossification
background therapy
author_facet A. A. Klimenko
A. A. Kondrashov
author_sort A. A. Klimenko
title Perioperative management of patients with rheumatic disorders: problems and solutions
title_short Perioperative management of patients with rheumatic disorders: problems and solutions
title_full Perioperative management of patients with rheumatic disorders: problems and solutions
title_fullStr Perioperative management of patients with rheumatic disorders: problems and solutions
title_full_unstemmed Perioperative management of patients with rheumatic disorders: problems and solutions
title_sort perioperative management of patients with rheumatic disorders: problems and solutions
publisher ABV-press
series Klinicist
issn 1818-8338
publishDate 2019-08-01
description Currently management of patients with rheumatic disorders (RD) involves not only application of all of the known spectrum of mediations in accordance with current guidelines and algorithms but also timely use of high-tech medical care, for example, endoprosthesis of the large joints, spinal surgery, dental care, endovascular surgery, aimed at decreasing the level of disability and improving patients’ quality of life. The article considers modern approaches to management of patients with RD in the perioperative period, special emphasis is given to administration of background anti-inflammatory and genetically engineered biological medications, as well as prevention of thrombosis of the deep veins and thromboembolic complications. In the postoperative period, use of pharmacological control of development of “painful endoprosthesis” is vital as it is the main cause of unsatisfaction with the outcome of orthopedic aid. An effective method for controlling pain syndrome in patients with RD is use of non-steroidal anti-inflammatory drugs (NSAIDs). Selection of a specific NSAID should be based on the knowledge of gastrointestinal and cardiovascular side effects, as well as evidence of effectiveness in the perioperative period. In the group of patients with RD, namely with ankylosing spondylitis and psoriatic arthritis, prevention of heterotopic ossification after orthopedic manipulations, endoprosthesis is very important. Considering high comorbidity in RD, it is necessary to determine perioperative risk taking into account patient’s condition and operative urgency: to evaluate clinical features of the main and concomitant disorder (ischemic heart disease, cerebrovascular pathology, diabetes mellitus, chronic kidney disease), type of the surgery, results of electrocardiogram at rest, lab tests, and other noninvasive procedures. Correct planning of management of the perioperative period in patients with RD, adequate pain relief prior to surgery and after it, early activization are the main elements of rehabilitation of patients with pathologies of the locomotor apparatus.
topic rheumatic disorders
perioperative period
endoprosthesis
pain relief
non-steroidal anti-inflammatory drugs
meloxicam
comorbidity
perioperative risk
“painful endoprosthesis”
heterotopic ossification
background therapy
url https://klinitsist.abvpress.ru/Klin/article/view/382
work_keys_str_mv AT aaklimenko perioperativemanagementofpatientswithrheumaticdisordersproblemsandsolutions
AT aakondrashov perioperativemanagementofpatientswithrheumaticdisordersproblemsandsolutions
_version_ 1721237078744760320